Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Breast: Page 38
DenseBreast-info updates site for health literacy
By
AuntMinnie.com staff writers
Advocacy group DenseBreast-info.org has completed a health literacy update of patient educational materials on its website, revising the site's language, images, and format to make content easier for patients to understand.
July 17, 2022
ECR: AI cuts radiologist workload by prioritizing mammography
By
Kate Madden Yee
Using an artificial intelligence (AI) algorithm to triage screening mammography exams for interpretation both cuts radiologists' recall rates and their daily reading list, according to a presentation delivered on July 16 at ECR 2022.
July 17, 2022
ECR: Don't fear lymphadenopathy after vaccination
By
Amerigo Allegretto
Researchers continue to gain ground in understanding lymphadenopathy caused by the COVID-19 vaccines, and several presenters discussed their findings on the topic on July 13 at ECR 2022.
July 14, 2022
ECR: U.S. expert urges annual breast screening starting at 40
By
Kate Madden Yee
VIENNA - U.S. research shows that annual breast cancer screening starting at age 40 is the most effective way to reduce mortality from the disease, according to a presentation delivered July 13 at ECR 2022 in Vienna.
July 13, 2022
ECR: What will breast imaging look like in 2025?
By
Amerigo Allegretto
Anything can happen three years from now, but that's not stopping breast imaging experts from making predictions for modalities within the next few years at the ECR in Vienna.
July 13, 2022
ECR: How has COVID affected cancer screening in Europe?
By
Kate Madden Yee
VIENNA - The COVID-19 pandemic dramatically affected how healthcare was delivered in Europe, and oncology screening programs were not immune from its impact, according to a panel of experts that convened on July 13 at ECR 2022 in Vienna.
July 12, 2022
Mass enhancement on contrast mammography tied to malignancy
By
Amerigo Allegretto
Mass enhancement on recombined images using contrast-enhanced mammography (CEM) is associated with malignancy, especially when linked to low-energy findings, a study published July 12 in
Radiology
found.
July 12, 2022
AI of ultrasound predicts lymph node reactions to COVID vax
By
Amerigo Allegretto
Artificial intelligence (AI) trained with ultrasound images can help differentiate between malignant lymph nodes from benign nodes that react as a side effect of COVID-19 vaccination, found researchers in a study published July 7 in the
European Journal of Radiology
.
July 10, 2022
COVID pandemic cut breast cancer screening volume by half
By
Amerigo Allegretto
The COVID-19 pandemic led to breast cancer screening worldwide falling by nearly half, a study published July 7 in
JAMA Oncology
has found. This could lead to a rise in deaths from cancer that could have been avoidable, researchers say.
July 7, 2022
DWI-MRI predicts whether women's DCIS will upstage after surgery
By
Kate Madden Yee
Preoperative diffusion-weighted MRI (DWI-MRI) is effective for predicting whether biopsy-confirmed ductal carcinoma in situ (DCIS) will be reclassified as invasive cancer after surgery, a study published July 5 in
Radiology
has found.
July 6, 2022
Week in Review: Ditching lead aprons | CMS rethinks PET payment limits | Contrast mammo vs. breast MRI
By
Brian Casey
June 30, 2022
FDA yanks MQSA certificate from imaging facility in Md.
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has revoked the certification under the Mammography Quality Standards Act (MQSA) of a mammography facility in Maryland that has a history of problems with image quality.
June 30, 2022
Previous Page
Page 38 of 573
Next Page